| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| B-Lymphocytes | 36 | 2022 | 726 | 3.160 |
Why?
|
| Lymphopoiesis | 12 | 2022 | 48 | 2.810 |
Why?
|
| Bone Marrow Cells | 22 | 2021 | 253 | 2.200 |
Why?
|
| Precursor Cells, B-Lymphoid | 5 | 2016 | 27 | 1.970 |
Why?
|
| Hematopoietic Stem Cells | 23 | 2022 | 292 | 1.930 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 8 | 2022 | 127 | 1.840 |
Why?
|
| Cell Lineage | 22 | 2016 | 280 | 1.780 |
Why?
|
| Cell Differentiation | 25 | 2022 | 1471 | 1.400 |
Why?
|
| Homeodomain Proteins | 8 | 2016 | 538 | 1.380 |
Why?
|
| Multipotent Stem Cells | 3 | 2014 | 19 | 1.020 |
Why?
|
| Lymphoid Progenitor Cells | 3 | 2013 | 16 | 0.960 |
Why?
|
| Flow Cytometry | 6 | 2021 | 680 | 0.930 |
Why?
|
| Immunity, Humoral | 1 | 2022 | 67 | 0.820 |
Why?
|
| Dendritic Cells | 3 | 2013 | 427 | 0.800 |
Why?
|
| Hematopoiesis | 15 | 2016 | 164 | 0.760 |
Why?
|
| Bone Marrow | 11 | 2018 | 435 | 0.750 |
Why?
|
| Transcription Factors | 8 | 2021 | 1580 | 0.730 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2018 | 136 | 0.690 |
Why?
|
| Mice | 49 | 2022 | 11438 | 0.660 |
Why?
|
| Killer Cells, Natural | 3 | 2018 | 267 | 0.640 |
Why?
|
| Mice, Knockout | 11 | 2016 | 1944 | 0.580 |
Why?
|
| Proto-Oncogene Proteins c-pim-1 | 1 | 2016 | 10 | 0.570 |
Why?
|
| Estrogens | 6 | 2013 | 200 | 0.570 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2016 | 5 | 0.550 |
Why?
|
| Animals | 57 | 2022 | 26650 | 0.550 |
Why?
|
| Mice, Inbred C57BL | 14 | 2016 | 3111 | 0.530 |
Why?
|
| Cell Proliferation | 5 | 2021 | 1598 | 0.510 |
Why?
|
| Immune System | 1 | 2016 | 93 | 0.510 |
Why?
|
| Trans-Activators | 7 | 2018 | 430 | 0.460 |
Why?
|
| B-Lymphocyte Subsets | 4 | 2010 | 40 | 0.460 |
Why?
|
| Signal Transduction | 8 | 2014 | 3264 | 0.400 |
Why?
|
| Antigens, CD | 8 | 2013 | 459 | 0.390 |
Why?
|
| Cell Survival | 6 | 2016 | 972 | 0.360 |
Why?
|
| Transcription, Genetic | 5 | 2013 | 1137 | 0.360 |
Why?
|
| Gene Expression Regulation, Developmental | 5 | 2008 | 649 | 0.350 |
Why?
|
| Genes, Immunoglobulin | 4 | 2005 | 111 | 0.350 |
Why?
|
| Cells, Cultured | 13 | 2021 | 2836 | 0.350 |
Why?
|
| Membrane Proteins | 5 | 2013 | 1200 | 0.330 |
Why?
|
| Lymphocytes | 6 | 2005 | 465 | 0.330 |
Why?
|
| Mice, Transgenic | 9 | 2021 | 1557 | 0.330 |
Why?
|
| Receptors, Interleukin-7 | 4 | 2013 | 28 | 0.310 |
Why?
|
| Proto-Oncogene Proteins | 5 | 2018 | 645 | 0.290 |
Why?
|
| Antigens, CD34 | 2 | 2018 | 158 | 0.270 |
Why?
|
| Pregnancy, Animal | 3 | 1994 | 58 | 0.270 |
Why?
|
| Apoptosis | 3 | 2011 | 1690 | 0.260 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 2 | 2005 | 37 | 0.260 |
Why?
|
| DNA-Binding Proteins | 9 | 2008 | 1214 | 0.250 |
Why?
|
| Transgenes | 2 | 2016 | 181 | 0.250 |
Why?
|
| Antigens, Ly | 2 | 2013 | 37 | 0.230 |
Why?
|
| Interleukin-7 | 6 | 2007 | 41 | 0.210 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2021 | 10 | 0.210 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2021 | 37 | 0.200 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2014 | 189 | 0.200 |
Why?
|
| Ligands | 1 | 2022 | 433 | 0.190 |
Why?
|
| Stem Cells | 4 | 2014 | 358 | 0.180 |
Why?
|
| Mice, Inbred BALB C | 13 | 2003 | 1059 | 0.180 |
Why?
|
| Antigens, CD19 | 3 | 2013 | 39 | 0.170 |
Why?
|
| Leukocyte Common Antigens | 3 | 2013 | 46 | 0.170 |
Why?
|
| Gene Expression Regulation | 2 | 2005 | 1928 | 0.170 |
Why?
|
| GATA2 Transcription Factor | 1 | 2018 | 14 | 0.170 |
Why?
|
| GATA1 Transcription Factor | 1 | 2018 | 18 | 0.170 |
Why?
|
| Cellular Senescence | 2 | 2016 | 94 | 0.150 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 152 | 0.150 |
Why?
|
| Membrane Glycoproteins | 5 | 2013 | 429 | 0.150 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2016 | 2 | 0.150 |
Why?
|
| GPI-Linked Proteins | 2 | 2013 | 50 | 0.150 |
Why?
|
| Growth and Development | 1 | 2016 | 12 | 0.150 |
Why?
|
| Lymphocyte Count | 2 | 2013 | 94 | 0.140 |
Why?
|
| Epistasis, Genetic | 1 | 2016 | 86 | 0.140 |
Why?
|
| Stress, Physiological | 1 | 2016 | 227 | 0.130 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 685 | 0.130 |
Why?
|
| Humans | 20 | 2021 | 85778 | 0.120 |
Why?
|
| Progesterone | 1 | 1994 | 110 | 0.120 |
Why?
|
| CD11c Antigen | 1 | 2013 | 11 | 0.120 |
Why?
|
| Janus Kinase 2 | 1 | 2014 | 57 | 0.120 |
Why?
|
| Gene Rearrangement | 3 | 2005 | 170 | 0.120 |
Why?
|
| Granulocyte-Macrophage Progenitor Cells | 1 | 2013 | 1 | 0.120 |
Why?
|
| Signaling Lymphocytic Activation Molecule Family Member 1 | 1 | 2013 | 4 | 0.120 |
Why?
|
| Platelet Membrane Glycoprotein IIb | 1 | 2013 | 5 | 0.120 |
Why?
|
| Receptors, Complement | 1 | 2013 | 46 | 0.120 |
Why?
|
| PAX5 Transcription Factor | 4 | 2008 | 32 | 0.110 |
Why?
|
| Gene Expression | 6 | 2012 | 1286 | 0.110 |
Why?
|
| Models, Immunological | 1 | 2013 | 80 | 0.110 |
Why?
|
| Repressor Proteins | 2 | 2008 | 405 | 0.110 |
Why?
|
| Arthritis | 1 | 2012 | 46 | 0.110 |
Why?
|
| B7-2 Antigen | 1 | 2012 | 40 | 0.110 |
Why?
|
| Stromal Cells | 6 | 2003 | 143 | 0.100 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2003 | 180 | 0.100 |
Why?
|
| Receptors, Cell Surface | 1 | 2013 | 288 | 0.100 |
Why?
|
| Adipocytes | 2 | 2003 | 154 | 0.100 |
Why?
|
| Lymphocyte Subsets | 3 | 2013 | 64 | 0.100 |
Why?
|
| Female | 18 | 2021 | 44216 | 0.100 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 1 | 2011 | 8 | 0.100 |
Why?
|
| Male | 15 | 2021 | 40652 | 0.100 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2011 | 35 | 0.100 |
Why?
|
| Cell Line | 6 | 2010 | 2474 | 0.100 |
Why?
|
| Immune Tolerance | 1 | 1993 | 337 | 0.100 |
Why?
|
| Gonadal Steroid Hormones | 4 | 2012 | 50 | 0.100 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 6479 | 0.090 |
Why?
|
| Homeostasis | 1 | 2013 | 402 | 0.090 |
Why?
|
| Cell Count | 1 | 2011 | 197 | 0.090 |
Why?
|
| Co-Repressor Proteins | 1 | 2010 | 18 | 0.090 |
Why?
|
| Haploinsufficiency | 1 | 2011 | 62 | 0.090 |
Why?
|
| Testosterone Propionate | 1 | 2010 | 1 | 0.090 |
Why?
|
| Adult Stem Cells | 1 | 2010 | 30 | 0.090 |
Why?
|
| Periaqueductal Gray | 1 | 2010 | 10 | 0.090 |
Why?
|
| Gene Silencing | 1 | 2010 | 174 | 0.090 |
Why?
|
| Heterozygote | 1 | 2011 | 366 | 0.090 |
Why?
|
| Immunoglobulin Variable Region | 3 | 2005 | 109 | 0.090 |
Why?
|
| Spleen | 4 | 2021 | 430 | 0.090 |
Why?
|
| Narcotics | 1 | 2010 | 69 | 0.090 |
Why?
|
| Mice, Mutant Strains | 3 | 2004 | 231 | 0.090 |
Why?
|
| Androgens | 1 | 2010 | 167 | 0.090 |
Why?
|
| Proteins | 3 | 2005 | 777 | 0.090 |
Why?
|
| Morphine | 1 | 2010 | 130 | 0.080 |
Why?
|
| RNA, Messenger | 8 | 2010 | 1986 | 0.080 |
Why?
|
| Lymphocyte Activation | 2 | 2009 | 733 | 0.080 |
Why?
|
| Pregnancy | 7 | 2010 | 2899 | 0.080 |
Why?
|
| Immunoglobulin Heavy Chains | 2 | 2005 | 131 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2005 | 882 | 0.070 |
Why?
|
| Cell Division | 5 | 2002 | 693 | 0.070 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 2 | 2003 | 36 | 0.070 |
Why?
|
| Receptors, Antigen, B-Cell | 2 | 2004 | 113 | 0.070 |
Why?
|
| Milk Proteins | 1 | 2005 | 24 | 0.070 |
Why?
|
| Genes, Regulator | 1 | 2005 | 65 | 0.060 |
Why?
|
| Genetic Complementation Test | 1 | 2004 | 97 | 0.060 |
Why?
|
| Thymus Gland | 5 | 2002 | 195 | 0.060 |
Why?
|
| Aged | 3 | 2018 | 18161 | 0.060 |
Why?
|
| Retroviridae | 1 | 2004 | 79 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 4 | 1996 | 1379 | 0.060 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2005 | 153 | 0.060 |
Why?
|
| Lymphocyte Depletion | 2 | 1994 | 97 | 0.060 |
Why?
|
| Cell Nucleus | 2 | 2005 | 581 | 0.060 |
Why?
|
| Myeloid Cells | 3 | 2012 | 98 | 0.060 |
Why?
|
| Dexamethasone | 1 | 2005 | 326 | 0.060 |
Why?
|
| Cytokines | 3 | 2000 | 780 | 0.060 |
Why?
|
| Chromatin | 3 | 2016 | 384 | 0.060 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2000 | 318 | 0.060 |
Why?
|
| Glucocorticoids | 1 | 2005 | 350 | 0.050 |
Why?
|
| Leukopoiesis | 1 | 2002 | 3 | 0.050 |
Why?
|
| Middle Aged | 3 | 2018 | 24740 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2005 | 338 | 0.050 |
Why?
|
| Dinoprostone | 1 | 2002 | 69 | 0.050 |
Why?
|
| Sulfur | 1 | 2021 | 28 | 0.050 |
Why?
|
| T-Lymphocytes | 2 | 2002 | 1200 | 0.050 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2001 | 17 | 0.050 |
Why?
|
| Binding Sites | 1 | 2004 | 1104 | 0.050 |
Why?
|
| Iron | 1 | 2021 | 164 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 4 | 2009 | 1041 | 0.050 |
Why?
|
| Bone Development | 1 | 2000 | 35 | 0.050 |
Why?
|
| Adult | 2 | 2018 | 25518 | 0.050 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2012 | 878 | 0.050 |
Why?
|
| Leukosialin | 1 | 2000 | 16 | 0.050 |
Why?
|
| Mutagenesis, Insertional | 1 | 2000 | 111 | 0.050 |
Why?
|
| Bromodeoxyuridine | 1 | 2000 | 57 | 0.050 |
Why?
|
| Sialoglycoproteins | 1 | 2000 | 31 | 0.050 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2000 | 95 | 0.040 |
Why?
|
| DNA Damage | 1 | 2021 | 366 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 3 | 2010 | 943 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 1999 | 80 | 0.040 |
Why?
|
| Colony-Forming Units Assay | 2 | 2000 | 40 | 0.040 |
Why?
|
| Adipose Tissue | 2 | 1992 | 241 | 0.040 |
Why?
|
| Animals, Newborn | 2 | 2010 | 516 | 0.040 |
Why?
|
| Oncogenes | 1 | 1998 | 88 | 0.040 |
Why?
|
| Mitochondria | 1 | 2021 | 536 | 0.040 |
Why?
|
| Sex Factors | 2 | 2012 | 1041 | 0.040 |
Why?
|
| Steroids | 2 | 2013 | 175 | 0.040 |
Why?
|
| Radiation Chimera | 2 | 2010 | 23 | 0.040 |
Why?
|
| Coculture Techniques | 2 | 2009 | 164 | 0.040 |
Why?
|
| Connective Tissue | 1 | 1996 | 23 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2001 | 551 | 0.030 |
Why?
|
| Immunophenotyping | 2 | 2009 | 211 | 0.030 |
Why?
|
| Regeneration | 1 | 2016 | 147 | 0.030 |
Why?
|
| Lipoprotein Lipase | 2 | 1992 | 14 | 0.030 |
Why?
|
| Enzyme Activation | 2 | 2009 | 694 | 0.030 |
Why?
|
| Integrins | 1 | 1994 | 76 | 0.030 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 3 | 2001 | 19 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2016 | 450 | 0.030 |
Why?
|
| Rats | 4 | 2010 | 3997 | 0.030 |
Why?
|
| Adiponectin | 2 | 2003 | 23 | 0.030 |
Why?
|
| Mice, Inbred NOD | 2 | 2005 | 188 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2005 | 349 | 0.030 |
Why?
|
| Lymphoid Tissue | 1 | 1993 | 57 | 0.030 |
Why?
|
| Estradiol | 1 | 1993 | 251 | 0.030 |
Why?
|
| Testosterone | 1 | 1994 | 271 | 0.030 |
Why?
|
| Arthritis, Experimental | 1 | 2012 | 24 | 0.030 |
Why?
|
| Growth Inhibitors | 2 | 2003 | 41 | 0.030 |
Why?
|
| Age Factors | 2 | 2010 | 1828 | 0.030 |
Why?
|
| Aging | 1 | 2016 | 689 | 0.030 |
Why?
|
| Fetal Blood | 2 | 2002 | 90 | 0.030 |
Why?
|
| Recombination, Genetic | 2 | 2005 | 439 | 0.030 |
Why?
|
| Mice, SCID | 2 | 2002 | 254 | 0.020 |
Why?
|
| Cell Line, Transformed | 2 | 2002 | 154 | 0.020 |
Why?
|
| HLA Antigens | 1 | 2012 | 232 | 0.020 |
Why?
|
| Phenotype | 2 | 2012 | 2389 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 1993 | 445 | 0.020 |
Why?
|
| Transplantation, Heterologous | 2 | 2002 | 363 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 1991 | 163 | 0.020 |
Why?
|
| Environment | 1 | 2012 | 219 | 0.020 |
Why?
|
| Models, Biological | 3 | 2005 | 1749 | 0.020 |
Why?
|
| Castration | 1 | 2010 | 41 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2010 | 74 | 0.020 |
Why?
|
| Molecular Sequence Data | 4 | 2000 | 3034 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 2005 | 929 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 1990 | 103 | 0.020 |
Why?
|
| Receptors, Transferrin | 1 | 2009 | 10 | 0.020 |
Why?
|
| Antigens, Differentiation | 1 | 1990 | 141 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 1992 | 504 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 115 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 2010 | 347 | 0.020 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 1989 | 47 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 1992 | 534 | 0.020 |
Why?
|
| Reaction Time | 1 | 2010 | 310 | 0.020 |
Why?
|
| Cell Communication | 1 | 2009 | 195 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2010 | 321 | 0.020 |
Why?
|
| Clone Cells | 3 | 1995 | 213 | 0.020 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2008 | 5 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2009 | 324 | 0.020 |
Why?
|
| Amino Acid Sequence | 3 | 2000 | 2065 | 0.020 |
Why?
|
| DNA, Complementary | 2 | 2000 | 394 | 0.020 |
Why?
|
| Immunoglobulin Light Chains | 2 | 2002 | 86 | 0.020 |
Why?
|
| Cell Adhesion | 3 | 1996 | 424 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2010 | 1218 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2010 | 447 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2009 | 716 | 0.020 |
Why?
|
| Immunoglobulin mu-Chains | 2 | 2000 | 18 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2008 | 508 | 0.020 |
Why?
|
| Octamer Transcription Factor-1 | 1 | 2005 | 18 | 0.020 |
Why?
|
| STAT5 Transcription Factor | 1 | 2005 | 42 | 0.020 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2005 | 30 | 0.020 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2005 | 35 | 0.020 |
Why?
|
| Receptors, Cytokine | 1 | 2005 | 28 | 0.020 |
Why?
|
| Genes, bcl-2 | 1 | 2005 | 16 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 135 | 0.020 |
Why?
|
| Hormone Antagonists | 1 | 2005 | 19 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2005 | 135 | 0.020 |
Why?
|
| Mifepristone | 1 | 2005 | 33 | 0.020 |
Why?
|
| Disease Progression | 1 | 2009 | 1458 | 0.020 |
Why?
|
| Dealkylation | 1 | 2004 | 3 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 2005 | 92 | 0.020 |
Why?
|
| CD79 Antigens | 1 | 2004 | 17 | 0.020 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2004 | 52 | 0.020 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2005 | 154 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2009 | 1938 | 0.020 |
Why?
|
| Myelopoiesis | 1 | 2003 | 10 | 0.010 |
Why?
|
| Prostaglandins | 1 | 2003 | 42 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2005 | 425 | 0.010 |
Why?
|
| Pre-B Cell Receptors | 1 | 2003 | 8 | 0.010 |
Why?
|
| Histones | 1 | 2005 | 311 | 0.010 |
Why?
|
| Antigens, CD7 | 1 | 2002 | 2 | 0.010 |
Why?
|
| Interferon Regulatory Factors | 1 | 2003 | 67 | 0.010 |
Why?
|
| Neprilysin | 1 | 2002 | 41 | 0.010 |
Why?
|
| Precipitin Tests | 2 | 1994 | 108 | 0.010 |
Why?
|
| Centromere | 1 | 2002 | 26 | 0.010 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2002 | 39 | 0.010 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2002 | 32 | 0.010 |
Why?
|
| Heterochromatin | 1 | 2002 | 22 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2002 | 94 | 0.010 |
Why?
|
| Immunoglobulin lambda-Chains | 1 | 2002 | 42 | 0.010 |
Why?
|
| Hormones | 1 | 2002 | 140 | 0.010 |
Why?
|
| Thiophenes | 1 | 2002 | 42 | 0.010 |
Why?
|
| Paracrine Communication | 1 | 2002 | 32 | 0.010 |
Why?
|
| Nuclear Envelope | 1 | 2002 | 36 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2002 | 99 | 0.010 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 2002 | 96 | 0.010 |
Why?
|
| CD5 Antigens | 1 | 2001 | 14 | 0.010 |
Why?
|
| Adipose Tissue, Brown | 1 | 2002 | 80 | 0.010 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Heavy Chain | 1 | 2001 | 20 | 0.010 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2001 | 74 | 0.010 |
Why?
|
| Complement Factor D | 2 | 1992 | 3 | 0.010 |
Why?
|
| Macrophage Colony-Stimulating Factor | 2 | 1992 | 18 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2003 | 381 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2002 | 270 | 0.010 |
Why?
|
| Kyphosis | 1 | 2000 | 14 | 0.010 |
Why?
|
| Fluoresceins | 1 | 2000 | 43 | 0.010 |
Why?
|
| Serine Endopeptidases | 2 | 1992 | 145 | 0.010 |
Why?
|
| Tibia | 1 | 2000 | 79 | 0.010 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2000 | 19 | 0.010 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2000 | 20 | 0.010 |
Why?
|
| Receptors, Interferon | 1 | 2000 | 31 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2000 | 307 | 0.010 |
Why?
|
| Models, Animal | 1 | 2001 | 264 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2002 | 1018 | 0.010 |
Why?
|
| Lumbar Vertebrae | 1 | 2000 | 147 | 0.010 |
Why?
|
| DNA Nucleotidylexotransferase | 1 | 1999 | 11 | 0.010 |
Why?
|
| Bone Density | 1 | 2000 | 208 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2001 | 503 | 0.010 |
Why?
|
| Interferon Type I | 1 | 2000 | 175 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2000 | 646 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2000 | 255 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2000 | 272 | 0.010 |
Why?
|
| Radiography | 1 | 2000 | 806 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 1998 | 72 | 0.010 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 1998 | 21 | 0.010 |
Why?
|
| Hyaluronan Receptors | 1 | 1998 | 36 | 0.010 |
Why?
|
| Graft Survival | 1 | 2001 | 885 | 0.010 |
Why?
|
| Depression, Chemical | 1 | 1996 | 28 | 0.010 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1996 | 23 | 0.010 |
Why?
|
| Base Sequence | 1 | 2000 | 2334 | 0.010 |
Why?
|
| Gene Library | 1 | 1996 | 131 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2001 | 1388 | 0.010 |
Why?
|
| Hybridomas | 1 | 1994 | 75 | 0.010 |
Why?
|
| Integrin beta1 | 1 | 1994 | 33 | 0.010 |
Why?
|
| Antibody Affinity | 1 | 1994 | 38 | 0.010 |
Why?
|
| Glycosylation | 1 | 1994 | 129 | 0.010 |
Why?
|
| Lymphoma | 1 | 1996 | 262 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1994 | 303 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2000 | 2240 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 1995 | 384 | 0.010 |
Why?
|
| Biomarkers | 1 | 1999 | 1697 | 0.010 |
Why?
|
| Fatty Acid-Binding Protein 7 | 1 | 1992 | 1 | 0.010 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 1992 | 9 | 0.010 |
Why?
|
| Blotting, Western | 1 | 1994 | 787 | 0.010 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 1992 | 34 | 0.010 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 1992 | 26 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1992 | 245 | 0.010 |
Why?
|
| Culture Media | 1 | 1992 | 147 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1992 | 258 | 0.010 |
Why?
|
| DNA | 1 | 1998 | 1294 | 0.010 |
Why?
|
| Receptors, Very Late Antigen | 1 | 1991 | 6 | 0.010 |
Why?
|
| Carcinoma, Renal Cell | 1 | 1996 | 424 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 1993 | 257 | 0.010 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 1991 | 56 | 0.010 |
Why?
|
| Genetic Markers | 1 | 1992 | 476 | 0.010 |
Why?
|
| Immunoglobulin Light Chains, Surrogate | 1 | 1991 | 4 | 0.010 |
Why?
|
| Proto-Oncogenes | 1 | 1991 | 61 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 1996 | 619 | 0.010 |
Why?
|
| Colony-Stimulating Factors | 1 | 1990 | 14 | 0.010 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 1990 | 11 | 0.010 |
Why?
|
| Angiotensinogen | 1 | 1990 | 5 | 0.010 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 1990 | 18 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1990 | 130 | 0.010 |
Why?
|
| Immunocompromised Host | 1 | 1991 | 140 | 0.010 |
Why?
|
| Apolipoproteins E | 1 | 1990 | 129 | 0.010 |
Why?
|
| Neoplasms, Experimental | 1 | 1991 | 269 | 0.010 |
Why?
|
| Biological Factors | 1 | 1989 | 18 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 1992 | 675 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 1990 | 197 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1991 | 428 | 0.000 |
Why?
|
| Nuclear Proteins | 1 | 1992 | 707 | 0.000 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1990 | 269 | 0.000 |
Why?
|
| In Vitro Techniques | 1 | 1989 | 991 | 0.000 |
Why?
|
| Lymph Nodes | 1 | 1990 | 533 | 0.000 |
Why?
|